Mast cell disease associated with acute myeloid leukemia:: Detection of a new c-kit mutation Asp816His

被引:0
|
作者
Pullarkat, VA
Pullarkat, ST
Calverley, DC
Brynes, RK
机构
[1] Univ So Calif, Div Hematol, Sch Med, Los Angeles, CA 90033 USA
[2] Univ So Calif, Dept Pathol, Sch Med, Los Angeles, CA 90033 USA
关键词
mast cell disease; acute myeloid leukemia; c-kit; mutation;
D O I
10.1002/1096-8652(200012)65:4<307::AID-AJH10>3.0.CO;2-F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mast cell disease (MCD), a proliferation of mast cells (MC), is occasionally associated with hematologic malignancies, Neoplastic NIC have activating c-kif mutations, c-kif is a receptor tyrosine kinase required for the development, proliferation, and survival of MC. Interaction of c-kit with its ligand stem cell factor induces dimerization, receptor phosphorylation, and signal transduction. The most common c-kit mutation detected in neoplastic MCD is Asp816Val, which results in ligand-independent autophosphorylation of the receptor leading to MC proliferation, We describe the rare occurrence of MCD associated with acute myeloid leukemia, report a novel c-kit mutation Asp816 His, and discuss the pathogenesis of MCD associated with hematologic malignancies. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:307 / 309
页数:3
相关论文
共 50 条
  • [21] A new D816 c-KIT gene mutation in refractory AML1-ETO leukemia
    Lasa, Adriana
    Carricondo, Maria T.
    Carnicer, Maria J.
    Perea, Granada
    Aventin, Anna
    Nomdedeu, Josep F.
    HAEMATOLOGICA, 2006, 91 (09) : 1283 - 1284
  • [22] Serum soluble c-kit receptor and expression of c-kit protein and mRNA in acute myeloid leukemia
    Tajima, F
    Kawatani, T
    Ishiga, K
    Nanba, E
    Kawasaki, H
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 60 (05) : 289 - 296
  • [23] Detection of the c-kit point mutation Asp816→Val in archival tissues of different sites in various subtypes of mastocytosis
    Sotlar, K
    Menke, DM
    Hartmann, K
    Bultmann, B
    Horny, H
    MODERN PATHOLOGY, 2003, 16 (01) : 253A - 253A
  • [24] Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis
    Worobec, AS
    Akin, C
    Scott, LM
    Metcalfe, DD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (03) : 523 - 524
  • [25] Detection of the c-kit point mutation asp816→Val in archival tissues of different sites in various subtypes of mastocytosis
    Sotlar, K
    Menke, DM
    Hartmann, K
    Bultmann, B
    Horny, H
    LABORATORY INVESTIGATION, 2003, 83 (01) : 253A - 253A
  • [26] Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease
    Pardanani, A
    Reeder, TL
    Kimlinger, TK
    Baek, JY
    Li, CY
    Butterfield, JH
    Tefferi, A
    LEUKEMIA RESEARCH, 2003, 27 (08) : 739 - 742
  • [27] Non c-Kit Tyrosine Kinase Expression In Mast Cell Leukemia
    Butterfield, Joseph H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB57 - AB57
  • [28] The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients
    Won, Dahae
    Chi, Hyun-Sook
    Shim, Hyoeun
    Jang, Seongsoo
    Park, Chan-Jeoung
    Lee, Je-Hwan
    LEUKEMIA RESEARCH, 2013, 37 (08) : 883 - 888
  • [29] c-kit activating mutations and mast cell proliferation in human leukemia
    Beghini, A
    Larizza, L
    Cairoli, R
    Morra, E
    BLOOD, 1998, 92 (02) : 701 - 702
  • [30] Neonatal mastocytosis: A case of systemic aggressive mast cell disease due to c-kit mutation
    Fowler, D. J.
    Sebire, N. J.
    Turnbull, C.
    Harper, J. I.
    Malone, M.
    JOURNAL OF PATHOLOGY, 2006, 210 : 53 - 53